Failure of repeated courses of high-dose intravenous immunoglobulin to induce stable remission in patients with chronic idiopathic thrombocytopenic purpura

C Schiavotto; M Ruggeri; F Rodeghiero

doi:10.1007/BF01834386

Failure of repeated courses of high-dose intravenous immunoglobulin to induce stable remission in patients with chronic idiopathic thrombocytopenic purpura

Ann Hematol. 1995 Feb;70(2):89-90. doi: 10.1007/BF01834386.

Authors

C Schiavotto¹, M Ruggeri, F Rodeghiero

Affiliation

¹ Department of Hematology, San Bortolo Hospital, Vicenza, Italy.

PMID: 7880930
DOI: 10.1007/BF01834386

Abstract

Repeated courses of HD IVIg are reported to induce stable remission in a significant proportion of adults with chronic refractory ITP. We have treated 14 such patients obtaining a remission rate quite comparable to the 5-10% of spontaneous remission.

Publication types

Clinical Trial

MeSH terms

Adult
Aged
Aged, 80 and over
Dose-Response Relationship, Drug
Female
Follow-Up Studies
Humans
Immunoglobulins, Intravenous / standards
Immunoglobulins, Intravenous / therapeutic use*
Male
Middle Aged
Purpura, Thrombocytopenic, Idiopathic / blood
Purpura, Thrombocytopenic, Idiopathic / drug therapy*
Remission Induction

Substances

Immunoglobulins, Intravenous